| scholarly article | Q13442814 |
| P50 | author | Liang-Yin Ke | Q82545660 |
| P2093 | author name string | Chao-Yuh Yang | |
| Richard A Dixon | |||
| Shyi-Jang Shin | |||
| Wen-Ter Lai | |||
| Chu-Huang Chen | |||
| Chih-Sheng Chu | |||
| Hsiang-Chun Lee | |||
| Hua-Chen Chan | |||
| Ming-Hsien Tsai | |||
| Yi-Ching Tung | |||
| Kai-Hung Cheng | |||
| Nicole Stancel | |||
| Hsiu-Chuan Chan | |||
| Chung-Ya Wang | |||
| P2860 | cites work | LDL electronegativity index: a potential novel index for predicting cardiovascular disease | Q26781851 |
| Electronegative LDL: a circulating modified LDL with a role in inflammation | Q27015769 | ||
| 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Q28301815 | ||
| Effect of simvastatin treatment on the electronegative low-density lipoprotein present in patients with heterozygous familial hypercholesterolemia | Q28373243 | ||
| Understanding the mechanism of LCAT reaction may help to explain the high predictive value of LDL/HDL cholesterol ratio | Q33715844 | ||
| Low-density lipoprotein electronegativity is a novel cardiometabolic risk factor | Q34156161 | ||
| Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association | Q34505315 | ||
| Electronegative low-density lipoprotein increases C-reactive protein expression in vascular endothelial cells through the LOX-1 receptor | Q34947183 | ||
| Statins and stroke: evidence for cholesterol-independent effects | Q35021033 | ||
| Associations between risk factors in childhood (12-13 years) and adulthood (48-49 years) and subclinical atherosclerosis: the Kaunas Cardiovascular Risk Cohort Study | Q35748063 | ||
| Prothrombotic lipoprotein patterns in stroke | Q36675043 | ||
| Plasma L5 levels are elevated in ischemic stroke patients and enhance platelet aggregation | Q36675073 | ||
| Effects of rosuvastatin on electronegative LDL as characterized by capillary isotachophoresis: the ROSARY Study | Q37299877 | ||
| Highly electronegative LDL from patients with ST-elevation myocardial infarction triggers platelet activation and aggregation | Q37334725 | ||
| Management of cardiovascular disease risk in chronic inflammatory disorders | Q37428743 | ||
| Electronegative low-density lipoprotein. A link between apolipoprotein B misfolding, lipoprotein aggregation and proteoglycan binding. | Q38042316 | ||
| The underlying chemistry of electronegative LDL's atherogenicity. | Q38217088 | ||
| Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis. | Q38647831 | ||
| Electronegative LDL induces priming and inflammasome activation leading to IL-1β release in human monocytes and macrophages. | Q38839004 | ||
| Should apolipoprotein B replace LDL cholesterol as therapeutic targets are lowered? | Q38889612 | ||
| Correlation in the human aorta of apo B fractions with tissue cholesterol and collagen content | Q40243255 | ||
| Increased LDL electronegativity in chronic kidney disease disrupts calcium homeostasis resulting in cardiac dysfunction | Q41075971 | ||
| The Induction of Cytokine Release in Monocytes by Electronegative Low-Density Lipoprotein (LDL) Is Related to Its Higher Ceramide Content than Native LDL. | Q41618607 | ||
| Bad cholesterol breaking really bad | Q42136244 | ||
| Carotid artery plaque and LDL-to-HDL cholesterol ratio predict atherosclerotic status in coronary arteries in asymptomatic patients with type 2 diabetes mellitus. | Q44937702 | ||
| Mediation of electronegative low-density lipoprotein signaling by LOX-1: a possible mechanism of endothelial apoptosis | Q46158845 | ||
| Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study | Q46942491 | ||
| Sesamol reduces the atherogenicity of electronegative L5 LDL in vivo and in vitro. | Q50451519 | ||
| Coronary Artery Disease and Diabetes Mellitus. | Q50912548 | ||
| Presence of a modified low density lipoprotein in humans. | Q51626919 | ||
| Aspirin protects human coronary artery endothelial cells against atherogenic electronegative LDL via an epigenetic mechanism: a novel cytoprotective role of aspirin in acute myocardial infarction. | Q54442432 | ||
| Impact of electronegative low-density lipoprotein on angiographic coronary atherosclerotic burden | Q58453138 | ||
| Fractionation of charge-modified low density lipoproteins by fast protein liquid chromatography | Q67822477 | ||
| Electronegative LDL from normolipemic subjects induces IL-8 and monocyte chemotactic protein secretion by human endothelial cells | Q73076629 | ||
| Isolation, Characterization, and Functional Assessment of Oxidatively Modified Subfractions of Circulating Low-Density Lipoproteins | Q73256291 | ||
| Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription | Q73269991 | ||
| Pro-apoptotic low-density lipoprotein subfractions in type II diabetes | Q79214003 | ||
| Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis | Q81147606 | ||
| Electronegative LDL circulating in smokers impairs endothelial progenitor cell differentiation by inhibiting Akt phosphorylation via LOX-1 | Q81381913 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | coronary artery disease | Q844935 |
| hyperlipidemia | Q1079120 | ||
| P304 | page(s) | 11866 | |
| P577 | publication date | 2018-08-08 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Range of L5 LDL levels in healthy adults and L5's predictive power in patients with hyperlipidemia or coronary artery disease | |
| P478 | volume | 8 |
| Q92569769 | Combined LDL and VLDL Electronegativity Correlates with Coronary Heart Disease Risk in Asymptomatic Individuals | cites work | P2860 |
Search more.